154 related articles for article (PubMed ID: 24130605)
21. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
[TBL] [Abstract][Full Text] [Related]
22. A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression.
Akhondzadeh S; Mostafavi SA; Keshavarz SA; Mohammadi MR; Hosseini S; Eshraghian MR
J Clin Pharm Ther; 2020 Feb; 45(1):134-143. PubMed ID: 31602695
[TBL] [Abstract][Full Text] [Related]
23. Effects of vitamin D supplementation on depressive symptoms in type 2 diabetes mellitus patients: Randomized placebo-controlled double-blind clinical trial.
Omidian M; Mahmoudi M; Abshirini M; Eshraghian MR; Javanbakht MH; Zarei M; Hasani H; Djalali M
Diabetes Metab Syndr; 2019; 13(4):2375-2380. PubMed ID: 31405646
[TBL] [Abstract][Full Text] [Related]
24. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.
Mukai Y; Tampi RR
Clin Ther; 2009 May; 31(5):945-61. PubMed ID: 19539096
[TBL] [Abstract][Full Text] [Related]
25. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
26. Antidepressants for depression in medical illness.
Gill D; Hatcher S
Cochrane Database Syst Rev; 2000; (4):CD001312. PubMed ID: 11034712
[TBL] [Abstract][Full Text] [Related]
27. The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder.
Clevenger SS; Malhotra D; Dang J; Vanle B; IsHak WW
Ther Adv Psychopharmacol; 2018 Jan; 8(1):49-58. PubMed ID: 29344343
[TBL] [Abstract][Full Text] [Related]
28. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial.
Kazemi A; Noorbala AA; Azam K; Eskandari MH; Djafarian K
Clin Nutr; 2019 Apr; 38(2):522-528. PubMed ID: 29731182
[TBL] [Abstract][Full Text] [Related]
29. Controlled trials of inositol in psychiatry.
Levine J
Eur Neuropsychopharmacol; 1997 May; 7(2):147-55. PubMed ID: 9169302
[TBL] [Abstract][Full Text] [Related]
30. Retraction of Vitamin D Supplementation Affects the Beck Depression Inventory, Insulin Resistance, and Biomarkers of Oxidative Stress in Patients with Major Depressive Disorder: A Randomized, Controlled Clinical Trial. J Nutr 2016;146(2):243-8.
J Nutr; 2021 May; 151(5):1360. PubMed ID: 33974698
[No Abstract] [Full Text] [Related]
31. An Expression of Concern from The Journal of Nutrition's Editorial Office about: Vitamin D Supplementation Affects the Beck Depression Inventory, Insulin Resistance, and Biomarkers of Oxidative Stress in Patients with Major Depressive Disorder: A Randomized, Controlled Clinical Trial.
Sepehrmanesh Z; Kolahdooz F; Abedi F; Mazroii N; Assarian A; Asemi Z; Esmaillzadeh A
J Nutr; 2020 Nov; 150(11):3043. PubMed ID: 33097954
[No Abstract] [Full Text] [Related]
32. Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial.
Solati Z; Jazayeri S; Tehrani-Doost M; Mahmoodianfard S; Gohari MR
Nutr Neurosci; 2015 May; 18(4):162-8. PubMed ID: 24621065
[TBL] [Abstract][Full Text] [Related]
33. Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
Salari S; Khomand P; Arasteh M; Yousefzamani B; Hassanzadeh K
Pharmacol Rep; 2015 Jun; 67(3):606-9. PubMed ID: 25933976
[TBL] [Abstract][Full Text] [Related]
34. Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant action.
Nowak G
Pharmacol Rep; 2015 Jun; 67(3):659-62. PubMed ID: 25933983
[TBL] [Abstract][Full Text] [Related]
35. Comparative absorption of zinc picolinate, zinc citrate and zinc gluconate in humans.
Barrie SA; Wright JV; Pizzorno JE; Kutter E; Barron PC
Agents Actions; 1987 Jun; 21(1-2):223-8. PubMed ID: 3630857
[TBL] [Abstract][Full Text] [Related]
36. Zinc Is Involved in Depression by Modulating G Protein-Coupled Receptor Heterodimerization.
Tena-Campos M; Ramon E; Lupala CS; Pérez JJ; Koch KW; Garriga P
Mol Neurobiol; 2016 Apr; 53(3):2003-2015. PubMed ID: 25855059
[TBL] [Abstract][Full Text] [Related]
37. Zinc status and serum testosterone levels of healthy adults.
Prasad AS; Mantzoros CS; Beck FW; Hess JW; Brewer GJ
Nutrition; 1996 May; 12(5):344-8. PubMed ID: 8875519
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis.
Schefft C; Kilarski LL; Bschor T; Köhler S
Eur Neuropsychopharmacol; 2017 Nov; 27(11):1090-1109. PubMed ID: 28988944
[TBL] [Abstract][Full Text] [Related]
39. Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness.
Maes M; Vandoolaeghe E; Neels H; Demedts P; Wauters A; Meltzer HY; Altamura C; Desnyder R
Biol Psychiatry; 1997 Sep; 42(5):349-58. PubMed ID: 9276075
[TBL] [Abstract][Full Text] [Related]
40. Zinc in the Glutamatergic Theory of Depression.
Mlyniec K
Curr Neuropharmacol; 2015; 13(4):505-13. PubMed ID: 26412070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
